NSE filing, NSE: UTIAMC. Summary written from the filing by ALFA Finder's alert engine.
UTI Asset Management Company Ltd: key numbers
- Share price
- ₹823.00
- Market cap
- ₹10,579 Cr
- Revenue (annual)
- ₹1,698 Cr
- Net profit (annual)
- ₹404.1 Cr
- P/E (TTM)
- 22.0×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 6.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from UTI Asset Management Company Ltd
All →UTI Asset Management Company Earnings Call Transcript: Key Takeaways
UTI AMC reports steady Q2 FY27 growth despite market volatility, focusing on its Mission 2031 strategy for AUM expansion.
UTI Asset Management Company Investor Presentation: Key Takeaways
UTI AMC Q2 FY27: consolidated revenue ₹414cr (-1% YoY), PAT ₹132cr (+17%), Core PAT ₹131cr (+22%). UTI MF QAAUM ₹4.02 lakh cr (+6.3% YoY); group AUM down 27% YoY on EPFO reallocation.
UTI Asset Management Company Q2 FY27 Results: Net Profit ₹132.3 Cr, Up 0.1% YoY
UTI Asset Management Company Ltd reported revenue from operations of ₹414.6 Cr (-1.0% YoY) and net profit of ₹132.3 Cr (+0.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹132.3 Cr · +0.1% YoY
UTI Asset Management Company Other Announcement
This document details the quarterly shareholding pattern for UTI Asset Management Company Ltd, providing a breakdown of share ownership as required by SEBI regulations.
UTI Asset Management Company Annual General Meeting
UTI AMC postal ballot results approved appointment of Narayan Subramaniam Ayypankav as Non-Executive Independent Director. E-voting concluded 7 October 2026 with requisite majority.
UTI Asset Management Company Legal & Regulatory
UTI AMC received an Income Tax penalty order for ₹3.32 Crore. The company intends to appeal the order before the appropriate appellate authority.
- Value
- ₹3.32 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.